Catheter Ablation of Valvular Atrial Fibrillation
|
|
|
- Victor Kelley Reeves
- 7 years ago
- Views:
Transcription
1 Catheter Ablation of Valvular Atrial Fibrillation Rong Bai, MD, FESC, FHRS Beijing Anzhen Hospital, Capital Medical University Beijing, China
2 NO CONFLICT OF INTEREST TO DECLARE
3 How to define valvular atrial fibrillation?! 2014 AHA/ACC/HRS Atrial Fibrillation Guidelines! Nonvalvular AF: AF in the absence of rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair.! 2012 ESC Atrial Fibrillation Guidelines! No satisfactory or uniform definition of these terms exists.! Valvular AF: AF related to rheumatic valvular disease (predominantly mitral stenosis), or prosthetic heart valves. J Am Coll Cardiol. 2014; 64: e1-76 Eur Heart J. 2012; 33:
4 Valvular heart disease & Atrial fibrillation! Valvular heart disease has been associated with a 1.8- and 3.4-fold increased risk for AF in men and women valvular heart disease increase LA pressure cause atrial myopathy alter wall stress increase susceptibility to AF! AF is the most common arrhythmia following surgery for valvular heart disease JAMA. 2004; 291(14): Circ Res. 2014; 114(9): J Am Coll Cardiol. 2014; 64: e1-76
5 Valvular atrial fibrillation & Thromboembolic risk! Valvular heart disease, independent of the underlying cardiac rhythm, is associated with an increased risk of thromboembolic events.! This risk is greatly amplified in the presence of AF. AF accompanying moderate-tosevere mitral stenosis and mechanical prosthetic valves particularly high risk of thromboembolism Valvular AF AF with mitral regurgitation, aortic stenosis or insufficiency do not increase the risk of thromboembolism AF in the presence of a bioprosthetic heart valve or after valve repair same risk of thromboembolism as with native valve Eur Heart J. 2014; 35(47):
6 Management of valvular atrial fibrillation! Rate control! Pharmacological agents for rate control! Rhythm control! Antiarrhythmic drugs! Catheter ablation! Surgical ablation
7 Catheter Ablation in AF Patients with Valvular Heart Disease Higher recurrence?
8 AF ablation in patients with valvular heart disease or prior open heart surgery! 102 pts with valve disease, 40 pts with prior openheart surgery, 194 pts as control! pulmonary vein antrum isolation+ superior vena cava isolation Heart Rhythm. 2004;1(1):33-9
9 Catheter ablation of persistent AF in patients with valvular heart diseases! Group I (51 pts with VHD), Group II (60 pts without VHD as control)! Circumferential pulmonary vein isolation(cpvi) + complex ractionated atrial electrogram (CFAE) ablation! FU: 12months Heart. 2009; 95(21):
10 No statistically significant difference in AF-free survival between the two groups Heart. 2009; 95(21):
11 Successful outcomes related to left atrium diameter (LAD) Group I Group II Heart. 2009; 95(21):
12 Catheter ablation of atrial Fibrillation in patients with valvular heart disease Group2 (without VHD) Group2 (without VHD) Group1 (with VHD) Group1 (with VHD)! Group1 (45 pts with moderate VHD), Group 2 (436 pts without VHD as control)! Excluded: history of valve surgery or other structural heart disease! pulmonary vein antrum isolation + LA linear ablation (persistent AF)! FU: 26 months J Cardiovasc Electrophysiol. 2010; 21(11):
13 Catheter Ablation in AF Patients With Mitral Mechanical Prosthetic Valve Risk of prosthetic valvular damage and entrapment of the ablation catheter?
14 Ablation of AF in patients with MVP is feasible Control Control MVP MVP! 26 pts with mitral valve prostheses (MVP), 52 pts without MVP as control! circumferential pulmonary vein ablation + mitral isthmus line (81%) + posterior left atrial line! FU: 12 months J Am Coll Cardiol. 2005; 45(6):
15 ! Higher complications! Greater radiation exposure! Higher incidence of post-ablation atrial tachycardia J Am Coll Cardiol. 2005; 45(6):
16 RF ablation for AF patients with prosthetic valves is feasible, safe, and efficacious Heart Rhythm. 2011; 8(7):
17 ! longer procedural and fluoroscopy times! higher recurrence rates for atrial flutter Heart Rhythm. 2011; 8(7):
18 Radiofrequency ablation of AF is feasible and safe for patients with MVR after a single ablation after the last ablation Control Control MVR MVR! 81 pts with mitral valve replacement (MVR), 162 pts without MVR as control! pulmonary vein antral isolation! 1.4±0.6 vs. 1.2±0.5 ablations per person in patients with and without MVR! FU: 24 months J Am Coll Cardiol. 2011; 58(6):
19 ! Similar incidence of procedure related complications J Am Coll Cardiol. 2011; 58(6):
20 Catheter Ablation of Atrial Fibrillation in Patients with Mechanical Mitral Valve: PVAI w/wo non-pv Trigger ablation J Cardiovasc Electrophysiol; 2014; 25(8):
21 LAPW LAA CS! Origin of non-pv triggers: CS 53.1%, LAA 62.5%, MV annulus 18.7%, LA roof/free wall 14.1%, interatrial septum 32.8%, and SVC or crista terminalis19.8% J Cardiovasc Electrophysiol; 2014; 25(8):
22 Catheter Ablation of Atrial Fibrillation in Patients with Mechanical Mitral Valve: PVAI w/wo non-pv Trigger ablation J Cardiovasc Electrophysiol; 2014; 25(8):
23 Catheter ablation of mitral annular flutter is feasible and safe in patients with prior MV replacement or repair! 21 pts with a history of MV surgery, 21 pts as control! mitral isthmus line ablation! FU: 6 months Heart Rhythm. 2011; 8(6):
24 Reviews: Advances in catheter ablation in AF patients with mitral mechanical prosthetic valve Curr Cardiol Rev. 2012; 8(4): 362-7
25 Reviews: Advances in catheter ablation in AF patients with mitral mechanical prosthetic valve Curr Cardiol Rev. 2012; 8(4): 362-7
26 Reviews: Advances in catheter ablation in AF patients with mitral mechanical prosthetic valve Curr Cardiol Rev. 2012; 8(4): 362-7
27 Comparison of Catheter Ablation and Surgical Ablation in Patients with AF and VHD Which is better?
28 Catheter ablation vs. Surgical CryoMaze procedure in patients with long-lasting persistent AF and RHD! patients with RHD and persistent AF pre-existing for more than 1 year! Group A (valvular operation and CPVI combined with substrate modification 6 months after the surgery), Group B (valvualr operation and concomitant Maze procedure with SICTRA)! Circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation! FU: 12months Eur Heart J. 2010; 31(21):
29 The concomitant Cox Maze procedure using SICTRA is more effective than subsequent CPVI combined with substrate modification Eur Heart J. 2010; 31(21):
30 Single procedure success seems to be higher with SICTRA after a single procedure FU: 48 months Int J Cardiol. 2013; 168(6):
31 Repeated catheter ablation potentially results in comparable outcomes in treating patients with LS-AF and RHD during 48 months follow-up 100,00% 80,00% P = after the last procedure 60,00% 40,00% P = 0.03 Group A Group B 20,00% 0,00% SR Re-ablation Int J Cardiol. 2013; 168(6):
32 Conclusions! Increased atrial size and pressure, surgical scarring and fibrosis, in addition to probable atrial myopathy from long-standing valvular disease potentially underlie arrhythmia recurrences following catheter ablation of valvular AF! AF ablation in patients with prosthetic valve is feasible and safe! Catheter ablation of valvular AF could achieve similar outcome to that of non-valvular AF; however, multiple procedures, atrial substrate modification on top of PVAI, longer procedure time and more X-ray exposure may be required.
33
How should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist
Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an
Surgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center
Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation Ashkan Babaie MD Providence Portland Medical Center 1 Disclosures None 2 Cox-Maze III The Godfather Cure rates > 95% in
Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial
Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels
Management of Symptomatic Atrial Fibrillation
Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015
DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012
DIU de rythmologie et stimulation cardiaque Titre : Fibrillation atriale paroxystique : ablation, résultats, complications Orateur : Serge BOVEDA Le 25 janvier 2012 Fibrillation Atriale Paroxystique :
Corporate Medical Policy
Corporate Medical Policy Catheter Ablation as a Treatment for Atrial Fibrillation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: catheter_ablation_as_a_treatment_for_atrial_fibrillation
How do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
Minimally Invasive Mitral Valve Surgery
Minimally Invasive Mitral Valve Surgery Stanford Health Care offers leading, superior options in cardiac surgery, including the latest techniques and research for Minimally Invasive Cardiac surgery. Advanced
Presenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip
The Decision Tree for Ablation Therapy in Atrial Fibrillation Colin Movsowitz, MD, FACC Cardiology Consultants of Philadelphia Director of Electrophysiology Einstein Medical Center Montgomery Co-Director
DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015
Death (%) Mortality (%) 9/16/2015 DISCLOSURE Atrial Fibrillation Management An Evidence-based Approach Jonathon Adams, MD, FHRS Relevant Financial Relationship(s) None Off Label Usage None OBJECTIVES What
ATRIAL FIBRILLATION: Scope of the Problem. October 2015
ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical
Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey
Europace (215) 17, 1596 16 doi:1.19/europace/euv2 EP WIRE Current techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Nikolaos Dagres 1 *, Maria Grazia
Managing the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
5. Management of rheumatic heart disease
5. Management of rheumatic heart disease The fundamental goal in the long-term management of RHD is to prevent ARF recurrences, and therefore, prevent the progression of RHD, and in many cases allow for
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Catheter Ablation as Treatment Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Catheter Ablation as Treatment Professional Institutional Original Effective
1547-5271/$ -see front matter 2007 by the Heart Rhythm Society and the European Heart Rhythm Association,
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up A report of the Heart Rhythm Society (HRS)
Management of Atrial Fibrillation in Heart Failure
Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation
Förmaksflimmer ablation - en uppdatering och guidelines. Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital.
Förmaksflimmer ablation - en uppdatering och guidelines Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital. Cardiac Surgery for AF management Maze I Maze II Maze III 1987-1992
Atrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014
Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Atrial Fibrillation 2 Atrial Fibrillation The most common arrhythmia encountered
Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
How do you decide on rate versus rhythm control?
How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous
Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation
Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Policy #: 283 Latest Review Date: June 2015 Category: Medical Policy Grade: A Background/Definitions:
Treatments to Restore Normal Rhythm
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
Atrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
A focus on atrial fibrillation
A focus on atrial fibrillation Is being female really a risk factor for stroke? Dr Justin Mariani MBBS BMedSci PhD FRACP FCSANZ Consultant Cardiologist and Interventional Heart Failure Specialist Alfred
Real-Time 3-Dimensional Transesophageal Echocardiography in the Evaluation of Post-Operative Mitral Annuloplasty Ring and Prosthetic Valve Dehiscence
Journal of the American College of Cardiology Vol. 53, No. 17, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.12.059
Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy
Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant
Atrial fibrillation (AF) is a common arrhythmia associated
Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia A New Anatomic Approach for Curing Atrial Fibrillation Carlo Pappone, MD, PhD; Salvatore Rosanio, MD, PhD; Giuseppe Oreto, MD; Monica Tocchi,
SECTION I: Request. SECTION II: Need. Program Description
SECTION I: Request This is a formal request for the Utah CARMA Center to be formally recognized by the University of Utah as a large, collaborative medical and academic center whose focus is on comprehensive
Anticoagulants in Atrial Fibrillation
Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014
ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 Facts 4 million or so people have atrial fibrillation 16 billion dollars spent yearly in USA 30% of strokes attributable to AF and AFL 3-5
Radiofrequency ablation of atrial tachycardia from no man s land
CASE REPORT 103 A case of atrial tachycardia originating between the His region and the non-coronary cusp Radiofrequency ablation of atrial tachycardia from no man s land Nikola Pavlović a,b, Sven Knecht
Atrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
National Medical Policy
National Medical Policy Subject: Policy Number: Catheter Ablation for Atrial Fibrillation NMP175 Effective Date*: May 2010 Update: July 2015 This National Medical Policy is subject to the terms in the
TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
Transcatheter Mitral Valve-in-Valve and Valve-in-Ring Implantations. Danny Dvir, MD On behalf of VIVID registry investigators
Transcatheter Mitral Valve-in-Valve and Valve-in-Ring Implantations Danny Dvir, MD On behalf of VIVID registry investigators Introduction Bioprosthetic valves are increasingly implanted in open-heart surgeries.
Updates to the Alberta Drug Benefit List. Effective January 1, 2016
Updates to the Alberta Drug Benefit List Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation
Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration
Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
CTA OF THE EXTRACORONARY HEART
CTA OF THE EXTRACORONARY HEART Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland NO DISCLOSURES CWHITE@UMM.EDU CARDIAC CASE DISTRIBUTION Coronary CTA 30% ED chest
Atrial Fibrillation and Ablation Therapy: A Patient s Guide
Atrial Fibrillation and Ablation Therapy: A Patient s Guide ATRIAL FIBRILLATION CENTER AT UNIVERSITY OF ROCHESTER MEDICAL CENTER www.heart.urmc.edu 585-275-4775 INTRODUCTION Our goal at the Atrial Fibrillation
Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
Advanced Treatment for Chronic Atrial Fibrillation
Advanced Treatment for Chronic Atrial Fibrillation Montefiore Einstein Heart Center New York City, NY April 1, 2009 Welcome to this OR Live webcast presentation, live Montefiore Einstein Heart Center in
Succesful Radiofrequency Ablation of Atrial Tachycardia Arising From Within the Coronary Venous Sinus
Succesful Radiofrequency Ablation of Atrial Tachycardia Arising From Within the Coronary Venous Sinus The Harvard community has made this article openly available. Please share how this access benefits
Approaches to Catheter Ablation for Persistent Atrial Fibrillation
The new england journal of medicine Original Article Approaches to Catheter Ablation for Persistent Atrial Fibrillation Atul Verma, M.D., Chen yang Jiang, M.D., Timothy R. Betts, M.D., M.B., Ch.B., Jian
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
Visited 9/14/2011. What is Atrial Fibrillation? What you need to know about Atrial Fibrillation. The Normal Heart Rhythm. 1 of 7 9/14/2011 10:50 AM
1 of 7 9/14/2011 10:50 AM Current URL: What you need to know about Atrial Fibrillation What is atrial fibrillation? What causes atrial fibrillation? How is atrial fibrillation diagnosed? What are the dangers
POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 27, 2015 Effective Date: April 1, 2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic
The debate: Should all AF patients see an EP consultant?
The debate: Should all AF patients see an EP consultant? Pre-debate show of hands in favour of the motion The argument for the motion: Dr Nick Kelland The argument against the motion: Dr Andy McCoye Discussion
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
CATHETER ABLATION for ATRIAL FIBRILLATION
CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street
Updates to the Alberta Human Services Drug Benefit Supplement
Updates to the Alberta Human Services Drug Benefit Supplement Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone
To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC
To Bridge or Not to Bridge Periop Anticoagulation Management Don Weinshenker, MD Ambulatory Care Denver VAMC Financial Disclosure Information Nothing to report Periop AC Management Chronically anti-coagulated
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin
Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin B. Keweloh 16.11.2013 Incidence of Atrial Fibrillation, Standard population
Radiofrequency Ablation for Atrial Fibrillation. A Guide for Adults
Radiofrequency Ablation for Atrial Fibrillation A Guide for Adults Fast Facts n There are different ways to treat atrial fibrillation (A-fib). One kind of treatment involves putting the heart back into
Practical class 3 THE HEART
Practical class 3 THE HEART OBJECTIVES By the time you have completed this assignment and any necessary further reading or study you should be able to:- 1. Describe the fibrous pericardium and serous pericardium,
Heart valve repair and replacement
16 Heart valve repair and replacement 222 Valvular heart disease can be treated in a variety of ways: valve replacement, in which an artificial (prosthetic) heart valve is implanted surgically to replace
Recurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy?
Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy? Carina Blomström Lundqvist Dept Cardiology, Uppsala University, Sweden Patterns of AF Terminates
National Medicines Information Centre
National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie THE CONTEMPORARY MANAGEMENT OF ATRIAL FIBRILLATION VOLUME 12 NUMBER 3 2006
Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital
Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial
Atrial fibrillation. Treatment Guide
Treatment Guide Atrial fibrillation Atrial fibrillation (AF or AFib) is the most common irregular or abnormal heart rhythm disorder, affecting more than 3 million Americans today. Thankfully, more options
Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time
page 1 HEART AS A PUMP A. Functional Anatomy of the Heart 1. Two pumps, arranged in series a. right heart: receives blood from the systemic circulation (via the great veins and vena cava) and pumps blood
How To Treat A Single Ventricle And Fontan
COACH Columbus Ohio Adult Congenital Heart Disease Program The Heart Center at Nationwide Children s Hospital & The Ohio State University Single Ventricle Defects Normal Heart Structure The heart normally
Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.
Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia
Medical publications on Arrhythmia and Its Interrelated Costs
DOCTORAL THESIS SHORT AND LONG TERM EFFECT OF NON- PHARMACOLOGICAL RATE CONTROL ON SYMPTOMATIC ATRIAL ARRHYTMIA REFLECTED BY THE CARDIO-PEPTIDE SERUM LEVEL CHANGES ANDRÁS CSABA DÉZSI M.D. SEMMELWEIS UNIVERSITY
Chapter 11. Natasja M.S de Groot, Jael Z. Atary, Nico A. Blom, Martin J. Schalij
Chapter Long-term outcome after ablative therapy of post-operative atrial tachyarrhythmias in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences. Natasja M.S
PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
Atrial Fibrillation (AF) March, 2013
Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one
STROKE PREVENTION IN ATRIAL FIBRILLATION
STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients
Press conference: Rheumatic Heart Disease a forgotten but devastating disease
www.worldcardiocongress.org Chairpersons: Bongani M. Mayosi Jonathan Carapetis Press conference: Rheumatic Heart Disease a forgotten but devastating disease www.worldcardiocongress.org www.worldcardiocongress.org
STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:
STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention
Cardiology Update 2014
Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. The
Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
Summa cardiovascular institute. A Patient s Guide to AFib Treatment
Summa cardiovascular institute A Patient s Guide to AFib Treatment Healthy Heart Atrial Fibrillation Risk Factors Normal impulse Sinoatrial (SA) node Left Atrium According to the Heart Rhythm Society,
Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
Atrial Fibrillation (AF) Explained
James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common
Diagnostic Electrophysiology & Ablation
Limited Ablation for Persistent Atrial Fibrillation Using Preprocedure Reverse Remodelling David Slotwiner 1 and Jonathan Steinberg 2 1. Assistant Professor of Cardiology, Hofstra North Shore-LIJ School
Il destino dei pazienti dopo ablazione della fibrillazione atriale
Tigullio Cardiologia 2014 La terapia della fibrillazione atriale: Il destino dei pazienti dopo ablazione della fibrillazione atriale N. Bottoni Responsabile U.O.S. Aritmologia Interventistica, Az. Ospedaliera
5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated
A Patient s Guide To with Atrial Fibrillation (AFib) CAUSES RISK FACTORS SYMPTOMS DIAGNOSIS TREATMENTS INSIDE The Healthy Heart... 2 Your Heart In AFib... 4 How Do You Get It?... 6 How Do You Know If You
Understanding your child s heart Atrial septal defect
Understanding your child s heart Atrial septal defect About this factsheet This factsheet is for the parents of babies and children who have an atrial septal defect (ASD). It explains, what an atrial septal